{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T21:08:56Z","timestamp":1782594536962,"version":"3.54.5"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.neuroscience.2006.12.004","type":"journal-article","created":{"date-parts":[[2007,1,10]],"date-time":"2007-01-10T15:06:46Z","timestamp":1168441606000},"page":"1-4","source":"Crossref","is-referenced-by-count":90,"title":["Anti-allodynic efficacy of botulinum neurotoxin A in a model of neuropathic pain"],"prefix":"10.1016","volume":"145","author":[{"given":"S.","family":"Luvisetto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Marinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Cobianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Pavone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2006.12.004_bib1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00702-004-0265-1","article-title":"Botulinum toxin type A in experimental neuropathic pain","volume":"112","author":"Bach-Rojecky","year":"2005","journal-title":"J Neural Transm"},{"key":"10.1016\/j.neuroscience.2006.12.004_bib2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/ncpneuro0113","article-title":"Mechanisms of disease: neuropathic pain: a clinical perspective","volume":"2","author":"Baron","year":"2006","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1016\/j.neuroscience.2006.12.004_bib3","doi-asserted-by":"crossref","first-page":"7739","DOI":"10.1073\/pnas.96.14.7739","article-title":"Distinct neurochemical features of acute and persistent pain","volume":"96","author":"Basbaum","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2006.12.004_bib4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man","volume":"33","author":"Bennett","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.neuroscience.2006.12.004_bib5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pain.2003.10.008","article-title":"Subcutaneous administration of botulinum toxin A reduces formalin-induced pain","volume":"107","author":"Cui","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.neuroscience.2006.12.004_bib6","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.tins.2005.06.001","article-title":"Beyond BOTOX: advantages and limitations of individual botulinum neurotoxins","volume":"28","author":"Davletov","year":"2005","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neuroscience.2006.12.004_bib7","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1001\/archneur.60.11.1524","article-title":"Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations","volume":"60","author":"Dworkin","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neuroscience.2006.12.004_bib8","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.neures.2003.12.005","article-title":"Sensory processing and functional reorganization of sensory transmission under pathological conditions in the spinal dorsal horn","volume":"48","author":"Furue","year":"2004","journal-title":"Neurosci Res"},{"key":"10.1016\/j.neuroscience.2006.12.004_bib9","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.tins.2004.03.014","article-title":"Organizing pains","volume":"27","author":"Garry","year":"2004","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neuroscience.2006.12.004_bib10","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1586\/14737175.5.6.823","article-title":"Combination pharmacotherapy for neuropathic pain: current evidence and future directions","volume":"5","author":"Gilron","year":"2005","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.neuroscience.2006.12.004_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(01)01302-4","article-title":"The clinical picture of neuropathic pain","volume":"429","author":"Jensen","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2006.12.004_bib12","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1146\/annurev.micro.53.1.551","article-title":"Clostridial toxins as therapeutic agents: benefits of nature\u2019s most toxic proteins","volume":"53","author":"Johnson","year":"1999","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.neuroscience.2006.12.004_bib13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1526-4637.2006.00100.x","article-title":"Botulinum toxin A relieved neuropathic pain in a case of post-herpetic neuralgia","volume":"7","author":"Liu","year":"2006","journal-title":"Pain Med"},{"key":"10.1016\/j.neuroscience.2006.12.004_bib14","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(99)01311-2","article-title":"Pain: an overview","volume":"353","author":"Loeser","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2006.12.004_bib15","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.brainres.2006.01.117","article-title":"Botulinum neurotoxins and formalin-induced pain: central vs. peripheral effects in mice","volume":"1082","author":"Luvisetto","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2006.12.004_bib16","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.neuroscience.2006.06.049","article-title":"Pain sensitivity in mice lacking the Cav2.1\u03b11 subunit of P\/Q-type Ca2+ channels","volume":"142","author":"Luvisetto","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2006.12.004_bib17","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.brainresrev.2005.11.004","article-title":"Immune and inflammatory mechanisms in neuropathic pain","volume":"51","author":"Moalem","year":"2006","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.neuroscience.2006.12.004_bib18","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.coph.2004.12.006","article-title":"Botulinal neurotoxins: revival of an old killer","volume":"5","author":"Montecucco","year":"2005","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.neuroscience.2006.12.004_bib19","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1602\/neurorx.2.4.650","article-title":"Challenges in the development of novel treatment strategies for neuropathic pain","volume":"2","author":"Ossipov","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.neuroscience.2006.12.004_bib20","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/BF03022619","article-title":"The effects of botulinum toxin A on mechanical and cold allodynia in a rat model of neuropathic pain","volume":"53","author":"Park","year":"2006","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.neuroscience.2006.12.004_bib21","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1146\/annurev.med.57.121304.131324","article-title":"New treatments for neuropathic pain","volume":"57","author":"Rice","year":"2006","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.neuroscience.2006.12.004_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.55.1.1","article-title":"Topical and peripherally acting analgesics","volume":"55","author":"Sawynok","year":"2003","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.neuroscience.2006.12.004_bib23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.pharmtox.44.101802.121554","article-title":"Identification of the major steps in botulinum toxin action","volume":"44","author":"Simpson","year":"2004","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.neuroscience.2006.12.004_bib24","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0304-3959(99)00154-2","article-title":"Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action","volume":"83","author":"Sindrup","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.neuroscience.2006.12.004_bib25","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1742-7843.2005.pto_96696601.x","article-title":"Antidepressants in the treatment of neuropathic pain","volume":"96","author":"Sindrup","year":"2005","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.neuroscience.2006.12.004_bib26","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/08990220400012539","article-title":"Contralateral input modulates the excitability of dorsal horn neurons involved in noxious signal processes","volume":"21","author":"Sotgiu","year":"2004","journal-title":"Somatosens Mot Res"},{"key":"10.1016\/j.neuroscience.2006.12.004_bib27","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/S0140-6736(99)01307-0","article-title":"Neuropathic pain: aetiology, symptoms, mechanisms, and management","volume":"353","author":"Woolf","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2006.12.004_bib28","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1126\/science.288.5472.1765","article-title":"Neuronal plasticity: Increasing the gain in pain","volume":"288","author":"Woolf","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2006.12.004_bib29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0014-2999(01)01303-6","article-title":"Pathobiology of neuropathic pain","volume":"429","author":"Zimmermann","year":"2001","journal-title":"Eur J Pharmacol"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452206016733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452206016733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T03:51:27Z","timestamp":1547092287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452206016733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0306452206016733"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2006.12.004","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}